BCM
AIMT

Beryl Capital Management’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Beryl Capital Management’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-90,498
Closed -$3.12M – 263
2020
Q3 		$3.12M Buy
+90,498
New +$3.12M 0.56% 36